1056 related articles for article (PubMed ID: 20846908)
1. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
[TBL] [Abstract][Full Text] [Related]
2. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
3. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.
Rupprecht S; Walther B; Gudziol H; Steenbeck J; Freesmeyer M; Witte OW; Günther A; Schwab M
Sleep Med; 2013 Nov; 14(11):1064-70. PubMed ID: 23948220
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
[TBL] [Abstract][Full Text] [Related]
5. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
[TBL] [Abstract][Full Text] [Related]
6. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
Stokholm MG; Iranzo A; Østergaard K; Serradell M; Otto M; Svendsen KB; Garrido A; Vilas D; Borghammer P; Santamaria J; Møller A; Gaig C; Brooks DJ; Tolosa E; Pavese N
Lancet Neurol; 2017 Oct; 16(10):789-796. PubMed ID: 28684245
[TBL] [Abstract][Full Text] [Related]
7. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
[TBL] [Abstract][Full Text] [Related]
8. Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with
Bae YJ; Kim JM; Kim KJ; Kim E; Park HS; Kang SY; Yoon IY; Lee JY; Jeon B; Kim SE
Radiology; 2018 Apr; 287(1):285-293. PubMed ID: 29232183
[TBL] [Abstract][Full Text] [Related]
9. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
Mossa EP; Niccoli Asabella A; Iuele F; Stabile Ianora AA; Giganti M; Rubini G
Recenti Prog Med; 2012 Nov; 103(11):500-4. PubMed ID: 23096739
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the substantia nigra echogenicity and
Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
[TBL] [Abstract][Full Text] [Related]
11. Transcranial sonography in idiopathic REM sleep behavior disorder and multiple system atrophy.
Li X; Xue S; Jia S; Zhou Z; Qiao Y; Hou C; Wei K; Zheng W; Rong P; Jiao J
Psychiatry Clin Neurosci; 2017 Apr; 71(4):238-246. PubMed ID: 27898200
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
13. Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder.
Iranzo A; Stefani A; Niñerola-Baizan A; Stokner H; Serradell M; Vilas D; Holzknecht E; Gaig C; Pavia J; Lomeña F; Reyes D; Seppi K; Santamaria J; Högl B; Tolosa E; Poewe W;
Neurology; 2020 Apr; 94(15):e1605-e1613. PubMed ID: 32161031
[TBL] [Abstract][Full Text] [Related]
14. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.
Miyamoto M; Miyamoto T; Iwanami M; Muramatsu S; Asari S; Nakano I; Hirata K
Sleep Med; 2012 Jan; 13(1):102-6. PubMed ID: 22033122
[TBL] [Abstract][Full Text] [Related]
15. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
[TBL] [Abstract][Full Text] [Related]
16. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.
Spiegel J; Hellwig D; Möllers MO; Behnke S; Jost W; Fassbender K; Samnick S; Dillmann U; Becker G; Kirsch CM
Brain; 2006 May; 129(Pt 5):1188-93. PubMed ID: 16513685
[TBL] [Abstract][Full Text] [Related]
17. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
18. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
19. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
Arnaldi D; Chincarini A; Hu MT; Sonka K; Boeve B; Miyamoto T; Puligheddu M; De Cock VC; Terzaghi M; Plazzi G; Tachibana N; Morbelli S; Rolinski M; Dusek P; Lowe V; Miyamoto M; Figorilli M; Verbizier D; Bossert I; Antelmi E; Meli R; Barber TR; Trnka J; Miyagawa T; Serra A; Pizza F; Bauckneht M; Bradley KM; Zogala D; McGowan DR; Jordan L; Manni R; Nobili F
Brain; 2021 Feb; 144(1):278-287. PubMed ID: 33348363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
